Retinoic acid receptor-independent mechanism of apoptosis of melanoma cells by the retinoid CD437 (AHPN)

Cell Death and Differentiation

Volumn 8, Issue 9, 2001, Pages 878-886

  Zhao, X ^a   Demary, K ^a   Wong, L ^a   Vaziri, C ^a   McKenzie, A B ^b   Eberlein, T J ^c   Spanjaard, R A ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Apoptosis; CD437; Differentiation; Melanoma; Retinoic acid receptor

Indexed keywords

4 [(5,6,7,8 TETRAHYDRO 5,5,8,8 TETRAMETHYL 2 NAPHTHYL)CARBOXAMIDO]BENZOIC ACID; 4 [1 HYDROXY 1 [5,6,7,8 TETRAHYDRO 5,5,8,8 TETRAMETHYL 2 NAPHTHYL] 2 PROPENYL]BENZOIC ACID; 6 [3 (1 ADAMANTYL) 4 HYDROXYPHENYL] 2 NAPHTHOIC ACID; ANTINEOPLASTIC AGENT; BENZOIC ACID DERIVATIVE; CD 2314; PROTEIN P21; PROTEIN P53; RETINOIC ACID RECEPTOR; RETINOID; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL CYCLE S PHASE; CELL DIFFERENTIATION; CELL GROWTH; CELL TYPE; CELL VIABILITY; CONTROLLED STUDY; DNA ADDUCT; DNA DAMAGE; DNA MICROARRAY; GENETIC TRANSCRIPTION; GROWTH INHIBITION; HUMAN; HUMAN CELL; MELANOMA CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN INDUCTION;

3T3 CELLS; ANIMALS; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; CELL DIVISION; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; DNA ADDUCTS; DNA DAMAGE; GENE EXPRESSION REGULATION, NEOPLASTIC; MELANOMA, EXPERIMENTAL; MICE; NUCLEAR PROTEINS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OLIGONUCLEOTIDES, ANTISENSE; ORGAN SPECIFICITY; PHOSPHOPROTEINS; RECEPTORS, RETINOIC ACID; RETINOIDS; RNA, MESSENGER; S PHASE; TRANSFECTION; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0034874421     PISSN: 13509047     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.cdd.4400894     Document Type: Article

References (52)

1. Multiplicity generates diversity in the retinoic acid signalling pathways
2. The roles of retinoids in vertebrate development
3. Retinoid-sensitive cells and cell lines
4. Retinoid-induced apoptosis in normal and neoplastic tissues
5. Suppression of retinoic acid receptor-beta in premalignant oral lesions and its up-regulation by isotretinoin
6. Retinoids and cancer: A basis for differentiation therapy
7. Clone 10d/BM28 (CDCL1), an early S-phase protein, is an important growth regulator of melanoma
8. Modulation by retinoids of mRNA levels for nuclear retinoic acid receptors in murine melanoma cells
9. The biological activity of retinoids in melanoma cells. Induction of expression of retinoic acid receptor-beta by retinoic acid in S91 melanoma cells
10. Evidence that retinoid X receptors mediate retinoid-dependent transcriptional activation of the retinoic acid receptor beta gene in S91 melanoma cells
11. Specific activation of retinoic acid receptors (RARs) and retinoid X receptors reveals a unique role for RARγ in induction of differentiation and apoptosis of S91 melanoma cells
12. Retinoid induced apoptosis in leukemia cells through a retinoic acid nuclear receptor-independent pathway
13. Induction of apoptosis in human non-small cell lung carcinoma cells by the novel synthetic retinoid CD437
14. Inhibition of cell proliferation and induction of apoptosis by the retinoid AHPN in human lung carcinoma cells
15. Overexpression of bcl-2 or bcl-XL fails to inhibit apoptosis mediated by a novel retinoid
16. Involvement of cyclin-dependent kinase activities in CD437-induced apoptosis
17. Molecular determinants of AHPN (CD437)-induced growth arrest and apoptosis in human lung cancer cell lines
18. Mechanisms of apoptosis induced by the synthetic retinoid CD437 in human non-small cell lung carcinoma cells
19. S-phase arrest and apoptosis induced in normal mammary epithelial cells by a novel retinoid
20. Implication of c-Myc in apoptosis induced by the retinoid CD437 in human lung carcinoma cells
21. Treatment of melanoma cells with the synthetic retinoid CD437 induces apoptosis via activation of AP-1 in vitro, and causes growth inhibition in xenografts in vivo
22. Post-transcriptional regulation of the DNA damage-inducible gadd45 gene in human breast carcinoma cells exposed to a novel retinoid CD437
23. Bcl-X(L) expression and its downregulation by a novel retinoid in breast carcinoma cells
24. p53 independent G0/G1 arrest and apoptosis induced by a novel retinoid in human breast cancer cells
25. The novel synthetic retinoid 6-[3-adamantyl-4-hydroxyphenyl]-2-naphthalene carboxylic acid (CD437) causes apoptosis in acute promyelocytic leukemia cells through rapid activation of caspases
26. Retinoid-induced apoptosis and Sp1 cleavage occur independently of transcription and require caspase activation
27. Signaling to p53: Breaking the mdm2-p53 circuit
28. Differential gene expression in CD3epsilon- and RAG1-deficient thymuses: Definition of a set of genes potentially involved in thymocyte maturation
29. Cyclin G is a transcriptional target of the p53 tumor suppressor protein
30. Identification and cloning of E124, a gene induced by p53 in etoposide-treated cells
31. ei24, a p53 response gene involved in growth suppression and apoptosis
32. Identification of synthetic retinoids with selectivity for human nuclear retinoic acid receptor gamma
33. 32P-postlabeling analysis of non-radioactive aromatic carcinogen-DNA adducts
34. Wild type p53 can mediate sequence-specific transactivation of an internal promoter within the mdm2 gene
35. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases
36. p21 is a universal inhibitor of cyclin kinases
37. Mitosis in transition
38. Transcriptional activation of the human p21 (WAF1/CIP1) gene by retinoic acid receptor. Correlation with retinoid induction of U937 cell differentiation
39. Suppression of cyclin D1 but not cdk4 or cyclin A with induction of melanoma terminal differentiation
40. Methional derived from 4-methylthio-2-oxobutanoate is a cellular mediator of apoptosis in BAF3 lymphoid cells
41. Cell type-specific inhibition of p53-mediated apoptosis by mdm2
42. MDM2 protein confers the resistance of a human glioblastoma cell line to cisplatin-induced apoptosis
43. Bypass of abnormal MDM2 inhibition of p53-dependent growth suppression
44. MDM2 protein overexpression promotes proliferation and survival of multiple myeloma cells
45. Transcriptional activation of the p21 (WAF1,CIP1,SDI1) gene by interleukin-6 type cytokines. A prerequisite for their pro-differentiating and anti-apoptotic effects on human osteoblastic cells
46. Induction of differentiation in human promyelocytic HL-60 leukemia cells activates p21, WAF1/CIP1, expression in the absence of p53
47. p53-dependent and independent expression of p21 during cell growth, differentiation, and DNA damage
48. Differential regulation of the p21/WAF-1 and mdm2 genes after high-dose UV irradiation: p53-dependent and p53-independent regulation of the mdm2 gene
49. Induction of apoptosis by the novel retinoid AHPN in human T-cell lymphoma cells involves caspase-dependent and independent pathways
50. Molecular characterization of mitochondrial apoptosis-inducing factor
51. The novel retinoid 6-[3-(1-adamantyl)-4-hydroxyphenyl]-2-naphtalene carboxylic acid can trigger apoptosis through a mitochondrial pathway independent of the nucleus
52. Butyrate-induced G1 arrest results from p21-independent disruption of retinoblastoma protein-mediated signals